Now that his nomination to be HHS secretary has cleared the full Senate, Alex Azar is likely to focus on advancing the government's development of policies to reduce drug prices in Medicare Part D and Part B.
Azar's nomination was approved by the Senate in a 55-43 vote, with support from five Democrats and one Independent. (See...